(Q51706058)

English

Clinical relevance of serum levels of matrix metallopeptidase-2, and tissue inhibitor of metalloproteinase-1 and -2 in patients with malignant melanoma.

scientific article published in April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/18419677

Clinical relevance of serum levels of matrix metallopeptidase-2, and tissue inhibitor of metalloproteinase-1 and -2 in patients with malignant melanoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/18419677

author name string

Yuichiro Yoshino

1

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/18419677

Toshiro Kageshita

2

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/18419677

Motowo Nakajima

3

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/18419677

Minako Funakubo

4

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/18419677

Hironobu Ihn

5

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/18419677

publication date

1 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/18419677

The Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/18419677

35

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/18419677

4

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/18419677

206-214

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/18419677

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2008.00446.X

21 January 2018

Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2008.00446.X

21 January 2018

Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2008.00446.X

21 January 2018

Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2008.00446.X

21 January 2018

Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2008.00446.X

21 January 2018

Matrix metalloproteinases in human melanoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2008.00446.X

21 January 2018

Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2008.00446.X

21 January 2018

Identifiers

10.1111/J.1346-8138.2008.00446.X

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/18419677

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/18419677

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51706058&oldid=937026885"